Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday1M Return

CASIFCASI Pharmaceuticals Inc+ 13.33%—
TECHBio-Techne Corp+ 0.01%+ 0.95%
ABBVAbbVie Inc− 1.43%+ 2.08%
Partial Period · Jul 31, 2026 — Sep 4, 2026

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

TECH+ 0.9%ABBV+ 2.1%Tap or hover the chart for values along the way

Metric	CASIFCASI Pharmaceuticals Inc	TECHBio-Techne Corp	ABBVAbbVie Inc
Return
Last Price	0.15	72.46	256.49
Daily Change	+ 13.33%	+ 0.01%	− 1.43%
Period ReturnPast Month	—	+ 0.95%	+ 2.08%Jul 31, 2026 — Sep 4, 2026
Valuation
Market Cap	$3.15 M	$11.3 B	$453 B
P/E Ratio	—	62.57	72.06
Dividend Yield	—	0.50%	4.47%
Net MarginTrailing 12M	—	15.0%	9.8%
Risk
Beta	—	1.30	0.20
52-Week Range	—	43.20 — $72.62	190.75 — $267.47
Company
Sector	—	Health Care	Health Care
Industry	Biotechnology	Life Sciences Tools & Services	Biotechnology

Company

CASIFBiotechnology
TECHHealth Care · Life Sciences Tools & Services
ABBVHealth Care · Biotechnology

Metrics could not be loaded for CASIF: P/E, dividend, beta and the 52-week range stay empty in that column.

FinnhubUpdated 21:53

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.